UBS(Lux)E.F.-Biotech(USD)P a.SEK/ LU1991432631 /
| NAV5/29/2024 | Chg.-8.8400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 940.5900SEK | -0.93% | reinvestment | Equity | UBS Fund M. (LU) ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 5/31/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 5/22/2024 | PRIIP Key Information Document | 2024 | English | 101.80 KB |
| 5/22/2024 | PRIIP Key Information Document | 2024 | German | 100.07 KB |
| 4/20/2024 | Prospectus | 2024 | English | 2,030.67 KB |
| 4/20/2024 | Prospectus | 2024 | German | 2,093.54 KB |
| 11/30/2023 | Account statment | 2023 | English | 2,674.34 KB |
| 11/30/2023 | Account statment | 2023 | German | 1,415.90 KB |
| 5/31/2023 | Semi-annual report | 2023 | English | 1,223.68 KB |
| 5/31/2023 | Semi-annual report | 2023 | German | 1,239.69 KB |
| 2/14/2022 | Key Investor Information | 2022 | German | 54.53 KB |
